KEWAUNEE SCIENTIFIC CORP /DE/
10-Q/A, 1995-11-16
LABORATORY APPARATUS & FURNITURE
Previous: KEMPER MONEY MARKET FUND, 485B24E, 1995-11-16
Next: LOUISIANA LAND & EXPLORATION CO, SC 13D/A, 1995-11-16





               UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                            Washington, DC  20549

                                  FORM 10-Q/A

/ X /     Quarterly Report Pursuant to Section 13 or 15(d) of the
          Securities Exchange Act of 1934

For the quarterly period ended July 31, 1995


/   /     Transition Report Pursuant to Section 13 or 15(d) of the
          Securities Exchange Act of 1934

For the transition period from            to
                               ----------    ------------

Commission file number 0-5286

                      KEWAUNEE SCIENTIFIC CORPORATION
                      --------------------------------
           (Exact name of registrant as specified in its charter)

          Delaware                                  38-0715562
- ----------------------------                    ------------------
(State or other jurisdiction of                  (I.R.S. Employer
 incorporation or organization)                 Identification No.)

2700 West Front Street
Statesville, North Carolina                           28677
- -----------------------------                   ------------------
(Address of principal executive offices)            (Zip Code)

                              (704) 873-7202
                        ----------------------------
            (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.  Yes    X     No
                                                    --------    --------

As of August 31, 1995, the Registrant had outstanding 2,366,717 shares of
Common Stock.

Pages:  This report, including exhibits, contains 4 pages numbered
sequentially from this cover page.

<PAGE>

                       KEWAUNEE SCIENTIFIC CORPORATION

                            INDEX TO FORM 10-Q/A

                FOR THE QUARTERLY PERIOD ENDED JULY 31, 1995


                                                             Page Number
                                                             -----------

PART II.  OTHER INFORMATION
- ---------------------------

Item 6.  Exhibits                                                2


SIGNATURE                                                        3
- ---------

                       PART II.  OTHER INFORMATION


Item 6.  Exhibits

     (a)  Exhibits

          Exhibit 27  Financial Data Schedule

<PAGE>

                               SIGNATURE


Pursuant to the requirements of the Securities and Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.


                                   KEWAUNEE SCIENTIFIC CORPORATION
                                   -------------------------------
                                           (Registrant)





Date:  November 16, 1995           By   /s/ D. Michael Parker
                                        ------------------------------
                                        D. Michael Parker
                                        Vice President of Finance
                                        Chief Financial Officer


<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          APR-30-1995
<PERIOD-END>                               JUL-31-1995
<CASH>                                         031,000
<SECURITIES>                                   350,000
<RECEIVABLES>                              015,538,000
<ALLOWANCES>                                       000
<INVENTORY>                                001,785,000
<CURRENT-ASSETS>                           019,158,000
<PP&E>                                     025,400,000
<DEPRECIATION>                             014,508,000
<TOTAL-ASSETS>                             030,564,000
<CURRENT-LIABILITIES>                      011,813,000
<BONDS>                                            000
<COMMON>                                   006,550,000
                              000
                                        000
<OTHER-SE>                                     007,674
<TOTAL-LIABILITY-AND-EQUITY>               030,564,000
<SALES>                                    015,548,000
<TOTAL-REVENUES>                           015,548,000
<CGS>                                      012,875,000
<TOTAL-COSTS>                              012,875,000
<OTHER-EXPENSES>                           002,415,000
<LOSS-PROVISION>                                   000
<INTEREST-EXPENSE>                             204,000
<INCOME-PRETAX>                                    070
<INCOME-TAX>                                       000
<INCOME-CONTINUING>                                070
<DISCONTINUED>                                     000
<EXTRAORDINARY>                                    000
<CHANGES>                                          000
<NET-INCOME>                                       070
<EPS-PRIMARY>                                      .03
<EPS-DILUTED>                                      .03
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission